REVIEW
|
doi:10.20944/preprints202409.1960.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Antibody drug-conjugate; biliary tract cancer; anti-HER2; payload; targeted therapy
Online: 25 September 2024 (09:00:59 CEST)